Chemicals - Specialty
Compare Stocks
5 / 10Stock Comparison
TSE vs EMN vs HUN vs AVNT vs KRO
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Chemicals
Chemicals - Specialty
Chemicals - Specialty
TSE vs EMN vs HUN vs AVNT vs KRO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty | Chemicals | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $5M | $8.43B | $2.56B | $3.35B | $811M |
| Revenue (TTM) | $3.13B | $8.64B | $5.69B | $3.28B | $1.88B |
| Net Income (TTM) | $-412M | $399M | $-324M | $158M | $-134M |
| Gross Margin | 6.2% | 19.8% | 12.9% | 31.7% | 10.1% |
| Operating Margin | -4.3% | 9.4% | -1.0% | 9.3% | -3.1% |
| Forward P/E | — | 12.5x | — | 12.0x | — |
| Total Debt | $2.48B | $5.08B | $2.73B | $1.92B | $577M |
| Cash & Equiv. | $210M | $566M | $429M | $511M | $37M |
TSE vs EMN vs HUN vs AVNT vs KRO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | Mar 26 | Return |
|---|---|---|---|
| Trinseo PLC (TSE) | 100 | 0.6 | -99.4% |
| Eastman Chemical Co… (EMN) | 100 | 110.9 | +10.9% |
| Huntsman Corporation (HUN) | 100 | 69.7 | -30.3% |
| Avient Corporation (AVNT) | 100 | 165.7 | +65.7% |
| Kronos Worldwide, I… (KRO) | 100 | 59.5 | -40.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TSE vs EMN vs HUN vs AVNT vs KRO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
TSE is the #2 pick in this set and the best alternative if dividends is your priority.
- 38.5% yield, vs AVNT's 2.9%
EMN ranks third and is worth considering specifically for efficiency.
- 2.6% ROA vs TSE's -15.8%, ROIC 6.7% vs -2.0%
HUN is the clearest fit if your priority is momentum.
- +37.5% vs TSE's -96.9%
AVNT carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 14 yrs, beta 1.19, yield 2.9%
- Rev growth 0.6%, EPS growth -51.6%, 3Y rev CAGR -1.4%
- Lower volatility, beta 1.19, Low D/E 80.6%, current ratio 1.66x
- Beta 1.19, yield 2.9%, current ratio 1.66x
KRO is the clearest fit if your priority is long-term compounding.
- 129.0% 10Y total return vs HUN's 57.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 0.6% revenue growth vs EMN's -6.7% | |
| Value | Better valuation composite | |
| Quality / Margins | 4.8% margin vs TSE's -13.2% | |
| Stability / Safety | Beta 1.19 vs TSE's 2.94 | |
| Dividends | 38.5% yield, vs AVNT's 2.9% | |
| Momentum (1Y) | +37.5% vs TSE's -96.9% | |
| Efficiency (ROA) | 2.6% ROA vs TSE's -15.8%, ROIC 6.7% vs -2.0% |
TSE vs EMN vs HUN vs AVNT vs KRO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
TSE vs EMN vs HUN vs AVNT vs KRO — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AVNT leads in 1 of 6 categories
EMN leads 1 • TSE leads 0 • HUN leads 0 • KRO leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AVNT leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EMN is the larger business by revenue, generating $8.6B annually — 4.6x KRO's $1.9B. AVNT is the more profitable business, keeping 4.8% of every revenue dollar as net income compared to TSE's -13.2%. On growth, KRO holds the edge at +4.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $3.1B | $8.6B | $5.7B | $3.3B | $1.9B |
| EBITDAEarnings before interest/tax | $88M | $1.2B | $160M | $445M | -$9M |
| Net IncomeAfter-tax profit | -$412M | $399M | -$324M | $158M | -$134M |
| Free Cash FlowCash after capex | -$96M | $498M | $135M | $205M | $35M |
| Gross MarginGross profit ÷ Revenue | +6.2% | +19.8% | +12.9% | +31.7% | +10.1% |
| Operating MarginEBIT ÷ Revenue | -4.3% | +9.4% | -1.0% | +9.3% | -3.1% |
| Net MarginNet income ÷ Revenue | -13.2% | +4.6% | -5.7% | +4.8% | -7.1% |
| FCF MarginFCF ÷ Revenue | -3.1% | +5.8% | +2.4% | +6.3% | +1.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -14.3% | -4.9% | +0.7% | +2.5% | +4.1% |
| EPS Growth (YoY)Latest quarter vs prior year | -23.5% | -40.8% | -3.3% | +3.8% | -126.1% |
Valuation Metrics
Evenly matched — HUN and AVNT each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 18.0x trailing earnings, EMN trades at a 56% valuation discount to AVNT's 41.0x P/E. On an enterprise value basis, EMN's 9.0x EV/EBITDA is more attractive than KRO's 40.7x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $5M | $8.4B | $2.6B | $3.3B | $811M |
| Enterprise ValueMkt cap + debt − cash | $2.3B | $12.9B | $4.9B | $4.8B | $1.4B |
| Trailing P/EPrice ÷ TTM EPS | -0.01x | 17.97x | -9.27x | 41.01x | -7.34x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 12.50x | — | 11.95x | — |
| PEG RatioP/E ÷ EPS growth rate | — | 5.59x | — | — | — |
| EV / EBITDAEnterprise value multiple | 13.84x | 8.96x | 19.64x | 12.22x | 40.71x |
| Price / SalesMarket cap ÷ Revenue | 0.00x | 0.96x | 0.45x | 1.03x | 0.44x |
| Price / BookPrice ÷ Book value/share | — | 1.41x | 0.86x | 1.40x | 1.08x |
| Price / FCFMarket cap ÷ FCF | — | 19.87x | 22.11x | 17.16x | — |
Profitability & Efficiency
EMN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
EMN delivers a 6.7% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-17 for KRO. KRO carries lower financial leverage with a 0.77x debt-to-equity ratio, signaling a more conservative balance sheet compared to HUN's 0.92x. On the Piotroski fundamental quality scale (0–9), TSE scores 5/9 vs HUN's 2/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | — | +6.7% | -8.1% | +6.6% | -17.0% |
| ROA (TTM)Return on assets | -15.8% | +2.6% | -4.6% | +2.6% | -9.4% |
| ROICReturn on invested capital | -2.0% | +6.7% | -0.6% | +3.9% | -1.9% |
| ROCEReturn on capital employed | -2.1% | +7.5% | -0.7% | +4.0% | -2.2% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 2 | 5 | 5 |
| Debt / EquityFinancial leverage | — | 0.84x | 0.92x | 0.81x | 0.77x |
| Net DebtTotal debt minus cash | $2.3B | $4.5B | $2.3B | $1.4B | $540M |
| Cash & Equiv.Liquid assets | $210M | $566M | $429M | $511M | $37M |
| Total DebtShort + long-term debt | $2.5B | $5.1B | $2.7B | $1.9B | $577M |
| Interest CoverageEBIT ÷ Interest expense | -0.43x | 2.22x | -1.08x | 3.61x | -2.32x |
Total Returns (Dividends Reinvested)
Evenly matched — EMN and KRO each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AVNT five years ago would be worth $7,726 today (with dividends reinvested), compared to $346 for TSE. Over the past 12 months, HUN leads with a +37.5% total return vs TSE's -96.9%. The 3-year compound annual growth rate (CAGR) favors EMN at 1.1% vs TSE's -76.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -80.6% | +15.8% | +45.5% | +16.0% | +58.5% |
| 1-Year ReturnPast 12 months | -96.9% | +2.3% | +37.5% | +4.1% | -1.2% |
| 3-Year ReturnCumulative with dividends | -98.7% | +3.4% | -33.3% | +2.3% | -0.7% |
| 5-Year ReturnCumulative with dividends | -96.5% | -28.4% | -39.8% | -22.7% | -43.9% |
| 10-Year ReturnCumulative with dividends | -79.8% | +35.4% | +57.6% | +27.8% | +129.0% |
| CAGR (3Y)Annualised 3-year return | -76.4% | +1.1% | -12.6% | +0.8% | -0.2% |
Risk & Volatility
Evenly matched — HUN and AVNT each lead in 1 of 2 comparable metrics.
Risk & Volatility
AVNT is the less volatile stock with a 1.19 beta — it tends to amplify market swings less than TSE's 2.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HUN currently trades 92.7% from its 52-week high vs TSE's 2.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.94x | 1.36x | 1.73x | 1.19x | 1.57x |
| 52-Week HighHighest price in past year | $4.42 | $84.18 | $15.89 | $44.85 | $7.90 |
| 52-Week LowLowest price in past year | $0.06 | $56.11 | $7.30 | $27.48 | $4.08 |
| % of 52W HighCurrent price vs 52-week peak | +2.8% | +87.5% | +92.7% | +81.4% | +89.2% |
| RSI (14)Momentum oscillator 0–100 | 39.2 | 56.9 | 65.4 | 55.2 | 63.4 |
| Avg Volume (50D)Average daily shares traded | 629K | 1.5M | 6.2M | 620K | 350K |
Analyst Outlook
Evenly matched — TSE and AVNT each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: EMN as "Buy", HUN as "Hold", AVNT as "Buy", KRO as "Hold". Consensus price targets imply 32.6% upside for AVNT (target: $48) vs -29.1% for KRO (target: $5). For income investors, TSE offers the higher dividend yield at 38.53% vs KRO's 2.84%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | — | $77.29 | $12.00 | $48.40 | $5.00 |
| # AnalystsCovering analysts | — | 35 | 33 | 20 | 7 |
| Dividend YieldAnnual dividend ÷ price | +38.5% | +4.5% | +5.7% | +2.9% | +2.8% |
| Dividend StreakConsecutive years of raises | 0 | 12 | 0 | 14 | 0 |
| Dividend / ShareAnnual DPS | $0.05 | $3.30 | $0.85 | $1.08 | $0.20 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.2% | +0.1% | +0.1% | 0.0% |
AVNT leads in 1 of 6 categories (Income & Cash Flow). EMN leads in 1 (Profitability & Efficiency). 4 tied.
TSE vs EMN vs HUN vs AVNT vs KRO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is TSE or EMN or HUN or AVNT or KRO a better buy right now?
For growth investors, Avient Corporation (AVNT) is the stronger pick with 0.
6% revenue growth year-over-year, versus -6. 7% for Eastman Chemical Company (EMN). Eastman Chemical Company (EMN) offers the better valuation at 18. 0x trailing P/E (12. 5x forward), making it the more compelling value choice. Analysts rate Eastman Chemical Company (EMN) a "Buy" — based on 35 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — TSE or EMN or HUN or AVNT or KRO?
On trailing P/E, Eastman Chemical Company (EMN) is the cheapest at 18.
0x versus Avient Corporation at 41. 0x. On forward P/E, Avient Corporation is actually cheaper at 12. 0x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — TSE or EMN or HUN or AVNT or KRO?
Over the past 5 years, Avient Corporation (AVNT) delivered a total return of -22.
7%, compared to -96. 5% for Trinseo PLC (TSE). Over 10 years, the gap is even starker: KRO returned +129. 0% versus TSE's -79. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — TSE or EMN or HUN or AVNT or KRO?
By beta (market sensitivity over 5 years), Avient Corporation (AVNT) is the lower-risk stock at 1.
19β versus Trinseo PLC's 2. 94β — meaning TSE is approximately 146% more volatile than AVNT relative to the S&P 500. On balance sheet safety, Kronos Worldwide, Inc. (KRO) carries a lower debt/equity ratio of 77% versus 92% for Huntsman Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — TSE or EMN or HUN or AVNT or KRO?
By revenue growth (latest reported year), Avient Corporation (AVNT) is pulling ahead at 0.
6% versus -6. 7% for Eastman Chemical Company (EMN). On earnings-per-share growth, the picture is similar: Trinseo PLC grew EPS 50. 3% year-over-year, compared to -228. 0% for Kronos Worldwide, Inc.. Over a 3-year CAGR, KRO leads at -1. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — TSE or EMN or HUN or AVNT or KRO?
Eastman Chemical Company (EMN) is the more profitable company, earning 5.
4% net margin versus -9. 9% for Trinseo PLC — meaning it keeps 5. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMN leads at 10. 6% versus -1. 7% for KRO. At the gross margin level — before operating expenses — AVNT leads at 32. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is TSE or EMN or HUN or AVNT or KRO more undervalued right now?
On forward earnings alone, Avient Corporation (AVNT) trades at 12.
0x forward P/E versus 12. 5x for Eastman Chemical Company — 0. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AVNT: 32. 6% to $48. 40.
08Which pays a better dividend — TSE or EMN or HUN or AVNT or KRO?
All stocks in this comparison pay dividends.
Trinseo PLC (TSE) offers the highest yield at 38. 5%, versus 2. 8% for Kronos Worldwide, Inc. (KRO).
09Is TSE or EMN or HUN or AVNT or KRO better for a retirement portfolio?
For long-horizon retirement investors, Avient Corporation (AVNT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
19), 2. 9% yield). Trinseo PLC (TSE) carries a higher beta of 2. 94 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AVNT: +27. 8%, TSE: -79. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between TSE and EMN and HUN and AVNT and KRO?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: TSE is a small-cap income-oriented stock; EMN is a small-cap deep-value stock; HUN is a small-cap income-oriented stock; AVNT is a small-cap quality compounder stock; KRO is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.